Overview

Treatment of Head & Neck Cancer With Chemotherapy and Radiation

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
Two new cancer treatment drugs called targeted therapies will be added to standard treatment for head and neck cancer to see if an improvement can be made in the effectiveness of treatment for this type of cancer. Treatment will include chemotherapy, radiation therapy and targeted therapy taken over a period of 4 months.
Phase:
Phase 2
Details
Lead Sponsor:
SCRI Development Innovations, LLC
Collaborator:
Genentech, Inc.
Treatments:
Albumin-Bound Paclitaxel
Bevacizumab
Carboplatin
Erlotinib Hydrochloride
Fluorouracil
Paclitaxel